A Seasonality-Adjusted Sequential Test for Vaccine Safety Surveillance
Biometrics · 2023
DOI: 10.1111/biom.13829 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biometrics, 2023. Verfasst von Rex Shen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Statistics and Biomedical Data Science, Stanford University, Stanford, California, USA. Hauptthemen laut MEDLINE: Adverse Drug Reaction Reporting Systems, Vaccines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Post-market active safety monitoring is important for the timely capture of safety signals associated with exposure to a new vaccine or drug. The group sequential analysis is a common method employed in safety surveillance. Specifically, it compares the post-vaccination incidence of adverse event (AE) in a vaccinated population with a pre-specified reference level by sequentially conducting hypothesis testing during the surveillance. When the number of AEs is “too high”, a safety signal is identified. If the null hypothesis is never rejected, the vaccine is considered safe. Such an approach does not account for either the variation in determining the reference risk from a control population or the seasonality effect. Furthermore, not rejecting the null could be due to a lack of power and cannot always be interpreted as proof of safety. In this paper, we proposed a new group sequential test procedure fully accounting for both seasonality and variation from the historical controls. More importantly, we proposed to construct a confidence interval for the relative AE risk between the exposed and control groups at the end of the study, which can be used to quantify the safety of the vaccine. The proposed method is illustrated via real-data examples on anaphylaxis and examined by extensive simulation studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Statistics and Biomedical Data Science, Stanford University, Stanford, California, USA.
- Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA.
Förderung
- NHLBI NIH HHS
Zitieren
APA
Shen, R., Moll, K., Lu, Y., & Tian, L. (2023). A Seasonality-Adjusted Sequential Test for Vaccine Safety Surveillance. Biometrics. https://doi.org/10.1111/biom.13829
Vancouver
Shen R, Moll K, Lu Y, Tian L. A Seasonality-Adjusted Sequential Test for Vaccine Safety Surveillance. Biometrics. 2023. doi:10.1111/biom.13829
BibTeX
@article{Shen2023,
author = {Shen, Rex and Moll, Keran and Lu, Ying and Tian, Lu},
title = {A Seasonality-Adjusted Sequential Test for Vaccine Safety Surveillance},
journal = {Biometrics},
year = {2023},
doi = {10.1111/biom.13829}
}
EUVIMED